Header Logo

Connection

LORETTA NASTOUPIL to Clinical Trials, Phase II as Topic

Back to Details
This is a "connection" page, showing publications LORETTA NASTOUPIL has written about Clinical Trials, Phase II as Topic.
LORETTA NASTOUPIL
Connection Strength
0.149
Clinical Trials, Phase II as Topic
  1. Standard-of-Care Axicabtagene Ciloleucel for Relapsed or Refractory Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium. J Clin Oncol. 2020 09 20; 38(27):3119-3128.
    View in: PubMed
    Score: 0.149
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.